Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease Petra PauluPavel OsmancikPetr Widimsky OriginalPaper 06 October 2012 Pages: 1 - 6
Identifying, monitoring and reducing preventable major bleeds in the hospital setting Deborah CaraballoAlex C. SpyropoulosCharles E. Mahan OriginalPaper 10 October 2012 Pages: 7 - 13
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus Antonio Tello-MontoliuJose Luis FerreiroDominick J. Angiolillo OriginalPaper 11 November 2012 Pages: 14 - 17
Neutrophil extracellular traps, scholarly debates, and public–private partnerships: highlights of the eighth annual Platelet Colloquium Patricia A. French OriginalPaper 16 March 2013 Pages: 18 - 21
Increased risk of minor bleeding and antiplatelet therapy cessation in patients with acute coronary syndromes and low on-aspirin platelet reactivity. A prospective cohort study Zenon HuczekKrzysztof J. FilipiakGrzegorz Opolski OriginalPaper Open access 18 September 2012 Pages: 22 - 30
Elevating local concentrations of GPIIb–IIIa antagonists counteracts platelet thrombus stability Henry E. SpeichRonit R. FurmanLisa K. Jennings OriginalPaper Open access 17 October 2012 Pages: 31 - 41
Multiple biomarkers for the prediction of short and long-term mortality after ST-segment elevation myocardial infarction: the Amsterdam Groningen collaboration Peter DammanMarthe A. KampingaRobbert J. de Winter OriginalPaper 30 September 2012 Pages: 42 - 46
Urinary prothrombin fragment 1+2 in patients with venous thrombosis and myocardial infarction J. van EsS. Biere-RafiV. E. A. Gerdes Letter to the Editor 22 December 2012 Pages: 47 - 49
Treatment with quercetin and 3′,4′-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo S. MosawyD. E. JacksonM. D. Linden OriginalPaper 16 October 2012 Pages: 50 - 57
Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up Nazim IsmaJuan MerloAnders Gottsäter OriginalPaper 18 December 2012 Pages: 58 - 64
New single nucleotide polymorphisms associated with differences in platelets reactivity in patients with type 2 diabetes treated with acetylsalicylic acid: genome-wide association approach and pooled DNA strategy Marek PostulaPiotr K. JanickiGrzegorz Opolski OriginalPaper 04 October 2012 Pages: 65 - 73
Large atrial thrombus at unusual site: masquerading atrial myxoma Yadvinder SinghJayashree KhargeManjunath Cholenahally Nanjappa Letter to the Editor 26 January 2013 Pages: 74 - 76
Vitamin B12 level in peripheral arterial disease Katalin S. ZsóriZoltán CsikiAmir-Houshang Shemirani OriginalPaper 16 September 2012 Pages: 77 - 83
Gender related differences in predictors of vascular complications: role of vessel size and BMI Bina AhmedStefan LischkeHarold L. Dauerman OriginalPaper 14 December 2012 Pages: 84 - 90
How one academic medical center has managed potency changes with unfractionated heparin Jeffery LalamaPatrick M. LewisJennifer Donovan OriginalPaper 14 October 2012 Pages: 91 - 95
Comparison of initial warfarin response in obese patients versus non-obese patients Jessica L. WallaceAnne B. ReavesTimothy H. Self OriginalPaper 27 September 2012 Pages: 96 - 101
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding D. ImbertiA. MagnacavalloW. Ageno OriginalPaper 11 October 2012 Pages: 102 - 108
Acquired FXIII inhibitors: a systematic review Massimo FranchiniFrancesco FrattiniCarlo Bonfanti OriginalPaper 14 October 2012 Pages: 109 - 114
Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), october 18–19, 2012, Belo Horizonte, Minas Gerais, Brazil Renato D. LopesRichard C. BeckerDavid A. Garcia OriginalPaper 14 March 2013 Pages: 115 - 130